Ma Kuang Healthcare Holding Limited Share Price

Equities

4139

KYG5831M1087

Healthcare Facilities & Services

End-of-day quote Taipei Exchange 03:30:00 03/05/2024 am IST 5-day change 1st Jan Change
30 TWD -1.48% Intraday chart for Ma Kuang Healthcare Holding Limited +1.01% -13.79%

Financials

Sales 2022 1.06B 32.8M 2.74B Sales 2023 1.22B 37.74M 3.15B Capitalization 1.48B 45.88M 3.83B
Net income 2022 -30M -929K -77.55M Net income 2023 -42M -1.3M -109M EV / Sales 2022 2.4 x
Net Debt 2022 737M 22.83M 1.9B Net Debt 2023 790M 24.46M 2.04B EV / Sales 2023 1.86 x
P/E ratio 2022
-57.9 x
P/E ratio 2023
-34.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 41.47%
More Fundamentals * Assessed data
Dynamic Chart
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Ma Kuang Healthcare Holding Limited Announces Resignation of Huang, Chang-I as Director CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Ma Kuang Healthcare Holding Limited Appoints Chen,Yi-Jun as Corporate Governance Officer CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Ma Kuang Healthcare Holding Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
MA KUANG HEALTHCARE HOLDING LIMITED Announces Dividend Distribution, Payable on September 23, 2021 CI
Ma Kuang Healthcare Holding Limited Announces Audit Committee Member Changes CI
More news
1 day-1.48%
1 week+1.01%
1 month-2.28%
3 months-18.14%
6 months-23.86%
Current year-13.79%
More quotes
1 week
29.70
Extreme 29.7
30.45
1 month
29.00
Extreme 29
31.60
Current year
27.70
Extreme 27.7
40.00
1 year
27.70
Extreme 27.7
45.00
3 years
27.70
Extreme 27.7
56.70
5 years
27.70
Extreme 27.7
70.81
10 years
22.86
Extreme 22.8618
72.53
More quotes
Managers TitleAgeSince
Founder - 01/99/01
Director of Finance/CFO - -
Chairman - 21/16/21
Members of the board TitleAgeSince
Founder - 01/99/01
Director/Board Member - 27/10/27
Chairman - 21/16/21
More insiders
Date Price Change Volume
03/24/03 30 -1.48% 304,133
02/24/02 30.45 +1.50% 4,010
30/24/30 30 -0.66% 301,167
29/24/29 30.2 +1.68% 12,005
26/24/26 29.7 0.00% 303,002

End-of-day quote Taipei Exchange, May 03, 2024

More quotes
Ma Kuang Healthcare Holding Limited is a Cayman Islands-based medical service provider. The Company provides services, including Traditional Chinese Medicine (TCM), western medicine, medical cosmetology, health management, medication and health products. The Company’s businesses include Singapore TCM Clinics, Tianjin Makuang Medical Chain, and Herbs Retail. Its Singapore TCM Clinics business operates approximately 20 TCM clinics and TuiNa centres distributed islandwide. The business offers various treatments, including TCM Consultation, Acupuncture, TuiNa Therapy, Cupping, Gua Sha/ Scrapping and TDP Lamp. It also provides Chinese medicinal powders, healthcare products and Chinese proprietary medicine. Tianjin Makuang Medical Chain business includes Medicare insurance designated community hospitals and medical cosmetology specialist hospitals. Herbs Retail business offers traditional Chinese herbs, such as bird’s nest, Ginseng, Antler horn, Ganoderma lucidum (LingZhi), and others.
More about the company